Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedMay 20, 2025
DataAggregated Company Financials
Companies10
- 7D-7.1%
- 3M-9.8%
- 1Y-27.3%
- YTD-9.4%
Over the last 7 days, the Pharma industry has dropped 7.1%, driven by a pullback from Merck KGaA of 8.1%. In contrast, MPH Health Care has gained 9.2%. The industry has fallen 27% in the last year. Looking forward, earnings are forecast to grow by 22% annually.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 21 May 2025 | €75.0b | €69.4b | -€206,564,479.00 | 18x | -363.2x | 1.1x |
| Fri, 18 Apr 2025 | €73.9b | €69.3b | €463.1m | 17.8x | 159.6x | 1.1x |
| Sun, 16 Mar 2025 | €84.0b | €69.2b | €436.0m | 21.1x | 192.7x | 1.2x |
| Tue, 11 Feb 2025 | €82.1b | €69.2b | €2.0b | 21.8x | 40.5x | 1.2x |
| Thu, 09 Jan 2025 | €84.3b | €69.2b | €2.0b | 23.1x | 41.9x | 1.2x |
| Sat, 07 Dec 2024 | €83.0b | €69.2b | €2.0b | 22.5x | 41x | 1.2x |
| Mon, 04 Nov 2024 | €93.9b | €69.4b | €1.6b | 20.1x | 60.2x | 1.4x |
| Wed, 02 Oct 2024 | €100.3b | €69.3b | €1.5b | 22.8x | 68.2x | 1.4x |
| Fri, 30 Aug 2024 | €105.8b | €69.4b | €1.5b | 25.8x | 71.8x | 1.5x |
| Sun, 28 Jul 2024 | €98.8b | €69.2b | -€303,627,757.00 | 29.5x | -325.3x | 1.4x |
| Tue, 25 Jun 2024 | €101.4b | €69.2b | -€327,989,929.00 | 30.8x | -309.2x | 1.5x |
| Thu, 23 May 2024 | €103.8b | €69.2b | -€310,351,180.00 | 21.8x | -334.3x | 1.5x |
| Sat, 20 Apr 2024 | €91.9b | €70.0b | -€34,208,180.00 | 20.1x | -2685.9x | 1.3x |
| Mon, 18 Mar 2024 | €96.5b | €70.0b | €6.5m | 19.8x | 14855.7x | 1.4x |
| Wed, 14 Feb 2024 | €95.9b | €70.6b | -€650,504,143.00 | 19.8x | -147.4x | 1.4x |
| Fri, 12 Jan 2024 | €97.6b | €70.6b | -€650,504,143.00 | 20.2x | -150.1x | 1.4x |
| Sun, 10 Dec 2023 | €95.8b | €70.6b | -€650,606,256.00 | 18.2x | -147.2x | 1.4x |
| Tue, 07 Nov 2023 | €107.6b | €72.1b | €4.7b | 17.6x | 23x | 1.5x |
| Thu, 05 Oct 2023 | €113.9b | €72.1b | €4.7b | 19.3x | 24.4x | 1.6x |
| Sat, 02 Sep 2023 | €125.5b | €72.1b | €4.7b | 22.2x | 27x | 1.7x |
| Mon, 31 Jul 2023 | €124.2b | €74.1b | €6.5b | 17.3x | 19.3x | 1.7x |
| Wed, 28 Jun 2023 | €118.6b | €74.2b | €6.4b | 18x | 18.4x | 1.6x |
| Fri, 26 May 2023 | €127.4b | €74.0b | €6.4b | 22x | 20x | 1.7x |
| Sun, 23 Apr 2023 | €134.9b | €74.2b | €7.6b | 20x | 17.7x | 1.8x |
| Tue, 21 Mar 2023 | €128.9b | €74.2b | €7.7b | 17.3x | 16.8x | 1.7x |
| Thu, 16 Feb 2023 | €143.8b | €72.8b | €8.4b | 15.3x | 17.2x | 2x |
| Sat, 14 Jan 2023 | €145.1b | €72.8b | €8.4b | 16.5x | 17.4x | 2x |
| Mon, 12 Dec 2022 | €133.0b | €72.8b | €8.4b | 15.7x | 15.9x | 1.8x |
| Wed, 09 Nov 2022 | €127.3b | €70.5b | €7.8b | 13x | 16.4x | 1.8x |
| Fri, 07 Oct 2022 | €123.6b | €70.5b | €7.8b | 13.2x | 15.9x | 1.8x |
| Sun, 04 Sep 2022 | €130.2b | €70.5b | €7.8b | 17.2x | 16.7x | 1.8x |
| Tue, 02 Aug 2022 | €139.7b | €67.8b | €5.6b | 25.2x | 24.9x | 2.1x |
| Thu, 30 Jun 2022 | €129.6b | €67.8b | €5.6b | 21.9x | 23.1x | 1.9x |
| Sat, 28 May 2022 | €146.1b | €67.8b | €5.6b | 24.3x | 26x | 2.2x |
Price to Earnings Ratio
26x
Current Industry PE
- Investors are pessimistic on the German Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 1.6x is higher than the industry's current PS ratio of 1.1x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | 0.79% | |
| Healthcare | -2.32% | |
| Pharma | -7.13% | |
| Pharma | -7.13% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HIGH Cantourage Group | €5.58 | 14.3% +€8.7m | -19.7% | PE877.5x | |
| 93M1 MPH Health Care | €25.10 | 6.4% +€6.4m | -2.7% | PE0.9x | |
| SBX SynBiotic | €3.21 | 6.7% +€1.4m | -66.0% | PS5.7x | |
| APPH Apontis Pharma | €11.25 | 0.4% +€416.5k | 23.6% | PE124.4x | |
| B8FK Biofrontera | €2.62 | 0.4% +€60.8k | -25.8% | PS0.7x |